These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacologic biomarkers in the development of stratified cancer medicine. Figg WD; Newell DR Clin Cancer Res; 2014 May; 20(10):2525-9. PubMed ID: 24831275 [TBL] [Abstract][Full Text] [Related]
4. Theory and practice of clinical pharmacodynamics in oncology drug development. Parchment RE; Doroshow JH Semin Oncol; 2016 Aug; 43(4):427-35. PubMed ID: 27663474 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic analyses in a multi-laboratory network: lessons from the poly(ADP-ribose) assay. Ferry-Galow KV; Ji J; Kinders RJ; Zhang Y; Czambel RK; Schmitz JC; Herzog J; Evrard YA; Parchment RE Semin Oncol; 2016 Aug; 43(4):492-500. PubMed ID: 27663481 [TBL] [Abstract][Full Text] [Related]
6. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573 [TBL] [Abstract][Full Text] [Related]
7. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools. Kagan J; Srivastava S; Barker PE; Belinsky SA; Cairns P Cancer Res; 2007 May; 67(10):4545-9. PubMed ID: 17510378 [TBL] [Abstract][Full Text] [Related]
9. National survey on the pre-analytical variability in a representative cohort of Italian laboratories. Lippi G; Montagnana M; Giavarina D; ; ; Clin Chem Lab Med; 2006; 44(12):1491-4. PubMed ID: 17163828 [TBL] [Abstract][Full Text] [Related]
10. Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens. Marrero A; Lawrence S; Wilsker D; Voth AR; Kinders RJ Semin Oncol; 2016 Aug; 43(4):453-63. PubMed ID: 27663477 [TBL] [Abstract][Full Text] [Related]
11. The physician's office laboratory: how does yours measure up? Mason CC Postgrad Med; 1978 Apr; 63(4):65-7, 70-2. PubMed ID: 345251 [TBL] [Abstract][Full Text] [Related]
12. Impact of proficiency testing program for laboratories conducting early diagnosis of HIV-1 infection in infants in low- to middle-income countries. Garcia A; Subbarao S; Zhang G; Parsons L; Nkengasong J; Ou CY; Ellenberger D J Clin Microbiol; 2014 Mar; 52(3):773-80. PubMed ID: 24353004 [TBL] [Abstract][Full Text] [Related]
13. Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST). Barker PE Ann N Y Acad Sci; 2003 Mar; 983():142-50. PubMed ID: 12724219 [TBL] [Abstract][Full Text] [Related]
14. Relationship between performance in three of the Centers for Disease Control microbiology proficiency testing programs and the number of actual patient specimens tested by participating laboratories. Griffin CW; Mehaffey MA; Cook EC; Blumer SO; Podeszwik PA J Clin Microbiol; 1986 Feb; 23(2):246-50. PubMed ID: 3009532 [TBL] [Abstract][Full Text] [Related]
15. Toward implementation of a regional quality assurance program in cytopathology: the Hong Kong experience. Ng WK; Chiu CS; Cheng Y; Chan ET; Chiu FL; Collins RJ; Acta Cytol; 2006; 50(2):164-77. PubMed ID: 16610684 [TBL] [Abstract][Full Text] [Related]
16. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal. Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J; J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391 [TBL] [Abstract][Full Text] [Related]
17. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays. Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479 [TBL] [Abstract][Full Text] [Related]
18. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network. Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062 [TBL] [Abstract][Full Text] [Related]
19. Validation of neurokinin a assays in the United States and Europe. Mamikunian P; Ardill JE; O'Dorisio TM; Krutzik SR; Vinik AI; Go VL; Armstrong L; Mamikunian G; Woltering EA Pancreas; 2011 Oct; 40(7):1000-5. PubMed ID: 21926539 [TBL] [Abstract][Full Text] [Related]
20. Association of clinical embryologists - guidelines on good practice in clinical embryology laboratories 2012. Hughes C; Hum Fertil (Camb); 2012 Dec; 15(4):174-89. PubMed ID: 23268725 [No Abstract] [Full Text] [Related] [Next] [New Search]